Joint Stock Forecast, Price & News

Joint (NASDAQ:JYNT) Frequently Asked Questions

Is Joint a buy right now?

6 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Joint in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Joint stock.
View analyst ratings for Joint or view top-rated stocks.

How has Joint's stock been impacted by Coronavirus (COVID-19)?

Joint's stock was trading at $13.61 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, JYNT shares have increased by 426.1% and is now trading at $71.60.
View which stocks have been most impacted by COVID-19.

When is Joint's next earnings date?

Joint is scheduled to release its next quarterly earnings announcement on Thursday, March 3rd 2022.
View our earnings forecast for Joint.

How were Joint's earnings last quarter?

The Joint Corp. (NASDAQ:JYNT) announced its quarterly earnings results on Thursday, November, 4th. The company reported $0.13 EPS for the quarter, topping analysts' consensus estimates of $0.04 by $0.09. Joint had a net margin of 23.18% and a trailing twelve-month return on equity of 34.65%. During the same quarter in the prior year, the business posted $0.11 EPS.
View Joint's earnings history.

What guidance has Joint issued on next quarter's earnings?

Joint issued an update on its FY 2021 earnings guidance on Thursday, December, 2nd. The company provided EPS guidance of for the period. The company issued revenue guidance of $80 million-$81 million, compared to the consensus revenue estimate of $79.42 million.

What price target have analysts set for JYNT?

6 equities research analysts have issued 12-month price targets for Joint's stock. Their forecasts range from $54.00 to $150.00. On average, they anticipate Joint's stock price to reach $107.83 in the next year. This suggests a possible upside of 50.6% from the stock's current price.
View analysts' price targets for Joint or view top-rated stocks among Wall Street analysts.

Who are Joint's key executives?

Joint's management team includes the following people:

• Peter D. Holt, President, Chief Executive Officer & Director
• Jorge Armenteros, Vice President-Operations
• Jacob Singleton, Chief Financial Officer & Controller (LinkedIn Profile)
• Manjula Sriram, Vice President-Information Technology
• Steve Knauf, Executive Director-Chiropractic & Compliance

What is Peter D. Holt's approval rating as Joint's CEO?

87 employees have rated Joint CEO Peter D. Holt on Glassdoor.com. Peter D. Holt has an approval rating of 59% among Joint's employees. This puts Peter D. Holt in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Joint's key competitors?

Some companies that are related to Joint include InterDigital (IDCC), Franchise Group (FRG), Liberty Tax (TAXA), Acacia Research (ACTG), Quarterhill (QTRHF), VirnetX (VHC), Pendrell (PCOA), Health Discovery (HDVY), Network-1 Technologies (NTIP), Research Frontiers (REFR), Xcel Brands (XELB), Mills Music Trust (MMTRS), ARC Group (ARCK), Micro Imaging Technology (MMTC) and ARC Group (RLLY).
View all of JYNT's competitors.

What other stocks do shareholders of Joint own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Joint investors own include Aurora Cannabis (ACB), Advanced Micro Devices (AMD), Raytheon Technologies (RTX), salesforce.com (CRM), Mastercard (MA), Starbucks (SBUX), Twitter (TWTR), Viking Therapeutics (VKTX), AbbVie (ABBV) and Adobe (ADBE).

When did Joint IPO?

(JYNT) raised $20 million in an initial public offering (IPO) on Tuesday, November 11th 2014. The company issued 3,000,000 shares at $6.50 per share. Roth Capital Partners and Feltl and Company served as the underwriters for the IPO and Sanders Morris Harris was co-manager.

What is Joint's stock symbol?

Joint trades on the NASDAQ under the ticker symbol "JYNT."

Who are Joint's major shareholders?

Joint's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (14.81%), Next Century Growth Investors LLC (2.43%), Skylands Capital LLC (2.30%), Dimensional Fund Advisors LP (2.03%), Invesco Ltd. (1.78%) and Geode Capital Management LLC (1.61%). Company insiders that own Joint stock include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, Matthew E Rubel and Ronald V Davella.
View institutional ownership trends for Joint.

Which major investors are selling Joint stock?

JYNT stock was sold by a variety of institutional investors in the last quarter, including Goldman Sachs Group Inc., Next Century Growth Investors LLC, Victory Capital Management Inc., Skylands Capital LLC, Wolverine Trading LLC, Invesco Ltd., Wasatch Advisors Inc., and Adell Harriman & Carpenter Inc.. Company insiders that have sold Joint company stock in the last year include Bandera Partners Llc, Glenn J Krevlin, Jake Singleton, James H Amos Jr, Matthew E Rubel, and Ronald V Davella.
View insider buying and selling activity for Joint or view top insider-selling stocks.

Which major investors are buying Joint stock?

JYNT stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Caption Management LLC, HAP Trading LLC, Dimensional Fund Advisors LP, Citadel Advisors LLC, Jane Street Group LLC, Renaissance Technologies LLC, and Morgan Stanley. Company insiders that have bought Joint stock in the last two years include Bandera Partners Llc, and Jake Singleton.
View insider buying and selling activity for Joint or or view top insider-buying stocks.

How do I buy shares of Joint?

Shares of JYNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Joint's stock price today?

One share of JYNT stock can currently be purchased for approximately $71.60.

How much money does Joint make?

Joint has a market capitalization of $1.03 billion and generates $58.68 million in revenue each year. The company earns $13.17 million in net income (profit) each year or $1.19 on an earnings per share basis.

How many employees does Joint have?

Joint employs 325 workers across the globe.

What is Joint's official website?

The official website for Joint is www.thejoint.com.

Where are Joint's headquarters?

Joint is headquartered at 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260.

How can I contact Joint?

Joint's mailing address is 16767 N PERIMETER DRIVE SUITE 240, SCOTTSDALE AZ, 85260. The company can be reached via phone at (480) 245-5960, via email at [email protected], or via fax at 480-513-7989.